Exo Therapeutics is a small molecule drug discovery and development company.
Exo Therapeutics has raised $78.0M in total funding. The most recent round was Series B. The last funding was announced in October 2021.
Exo Therapeutics's investors include Samsara BioCapital, CRV, Newpath Management, Casdin Capital, Nextech Invest.
Exo Therapeutics is headquartered in Cambridge, United States.
Exo Therapeutics is a small molecule drug discovery and development company.
Exo Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Exo Therapeutics — Funding & Investors." VCBacked, October 5, 2021, https://www.vcbacked.co/company/exo-therapeutics. Accessed November 15, 2026.
VCBacked. (2021). Exo Therapeutics — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/exo-therapeutics
{{cite web |title=Exo Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/exo-therapeutics |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Exo Therapeutics? Request a listing update